Research Topic · Peer-Reviewed

Calcium Antagonist Therapy

Calcium antagonists, also known as calcium channel blockers, are a commonly prescribed medication for the treatment of hypertension and certain heart conditions. They work by blocking the movement of calcium into cells in the heart and blood vessels, thus reducing the amount of contraction and dilating the vessels. …

Curated from this journal's research 📚 1 peer-reviewed article cited Cited 1× across the literature 🔖 ISSN 2329-9487 🗓 Reviewed July 2026

Overview

Calcium antagonists, also known as calcium channel blockers, are a commonly prescribed medication for the treatment of hypertension and certain heart conditions. They work by blocking the movement of calcium into cells in the heart and blood vessels, thus reducing the amount of contraction and dilating the vessels. This leads to lower blood pressure and improved blood flow in the body. Calcium antagonists are particularly effective in treating hypertension in elderly patients and those with certain co-existing medical conditions, such as angina or peripheral vascular disease. They can also be helpful in managing certain heart conditions, such as atrial fibrillation or supraventricular tachycardia. Some common calcium antagonists include amlodipine, verapamil, and diltiazem. These medications are available in both short-acting and long-acting forms, and can be taken orally or intravenously, depending on the individual patient's needs. Like all medications, calcium antagonists can have side effects, such as dizziness, flushing, nausea, and constipation. Patients should also be aware of the potential for interactions with other medications, particularly those that affect the heart or blood pressure. If you have been diagnosed with hypertension or a heart condition and are considering calcium antagonist therapy, talk to your healthcare provider about the benefits and risks of this treatment option. With proper monitoring and management, calcium antagonists can be an effective tool in achieving better heart health.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

How this research is being cited

The 1 article above has been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.

A sample of recent works citing this journal's research on Calcium Antagonist Therapy, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hypertension and Cardiology (ISSN 2329-9487).

Journal editorial board
Hatori Nobuo · Japan Gregor Leibundgut · Switzerland Yuejin Li · United States

This page summarises published research for orientation; it is not medical or professional advice.